Global Blood Pressure Monitoring and Measurement Instruments Market to Reach $4.3 Billion by 2030
The global market for Blood Pressure Monitoring and Measurement Instruments estimated at US$2.1 Billion in the year 2022, is projected to reach a revised size of US$4.3 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2022-2030. Sphygmomanometers, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Automated / Digital Blood Pressure Monitor segment is readjusted to a revised 11.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $573.5 Million, While China is Forecast to Grow at 13.3% CAGR
The Blood Pressure Monitoring and Measurement Instruments market in the U.S. is estimated at US$573.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$957.5 Million by the year 2030 trailing a CAGR of 13.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 7.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.Select Competitors (Total 46 Featured) -
- A&D Medical
- American Diagnostic Corporation
- Beurer GmbH
- Bokang Instruments Co., Ltd.
- Briggs Healthcare
- Draegerwerk AG & Co., KGaA
- GE Healthcare Ltd.
- GF Health Products Inc.
- HealthSTATS International Pte Ltd.
- iHealth Labs, Inc.
- Jitron Pte Ltd.
- Medel International srl
- Microlife AG
- Omron Healthcare Co., Ltd.
- Philips Healthcare
- Rossmax International Ltd.
- Shenzhen Kingyield Technology Co., Ltd.
- Spacelabs Healthcare Inc.
- SunTech Medical Inc.
- Welch Allyn Inc.
- Withings
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A&D Medical
- American Diagnostic Corporation
- Beurer GmbH
- Bokang Instruments Co., Ltd.
- Briggs Healthcare
- Draegerwerk AG & Co., KGaA
- GE Healthcare Ltd.
- GF Health Products Inc.
- HealthSTATS International Pte Ltd.
- iHealth Labs, Inc.
- Jitron Pte Ltd.
- Medel International srl
- Microlife AG
- Omron Healthcare Co., Ltd.
- Philips Healthcare
- Rossmax International Ltd.
- Shenzhen Kingyield Technology Co., Ltd.
- Spacelabs Healthcare Inc.
- SunTech Medical Inc.
- Welch Allyn Inc.
- Withings
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 193 |
Published | April 2024 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 1.7 Billion |
Forecasted Market Value ( USD | $ 3.2 Billion |
Compound Annual Growth Rate | 9.5% |
Regions Covered | Global |